Pancreatic Safety of Once-Weekly Dulaglutide in Chinese Patients with Type 2 Diabetes Mellitus: Subgroup Analysis by Potential Influencing Factors

被引：0
|
作者：
Yan Zhou
Jiankun Zhu
Haiya Wu
Yuying Deng
Qiuhe Ji
机构：
[1] Endocrinology Department of Xi’an International Medical Center Hospital,
[2] Lilly Suzhou Pharmaceutical Co. Ltd.,undefined
[3] Endocrinology Department of the First Affiliated Hospital (Xijing Hospital) of Air Force Medical University,undefined
来源：
Diabetes Therapy | 2021年 / 12卷
关键词：
Chinese patient; Dulaglutide; Pancreatic safety; Subgroup analysis; Type 2 diabetes;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2677 / 2690
页数：13
相关论文
共 50 条
  • [1] Pancreatic Safety of Once-Weekly Dulaglutide in Chinese Patients with Type 2 Diabetes Mellitus: Subgroup Analysis by Potential Influencing Factors
    Zhou, Yan
    Zhu, Jiankun
    Wu, Haiya
    Deng, Yuying
    Ji, Qiuhe
    [J]. DIABETES THERAPY, 2021, 12 (10) : 2677 - 2690
  • [2] Efficacy and safety of once-weekly dulaglutide monotherapy compared to glimepiride in Chinese patients with type 2 diabetes mellitus
    Wang, Weiqing
    Li, Pengfei
    Yang, Jun
    Gu, Liqun
    [J]. DIABETES-METABOLISM RESEARCH AND REVIEWS, 2015, 31 : 10 - 11
  • [3] Efficacy and Safety of Once Weekly Dulaglutide in East Asian Patients with Type 2 Diabetes: Subgroup Analysis by Potential Influential Factors
    Ma, Jianhua
    Zhang, Bin
    Hou, Jianing
    Peng, Yongde
    [J]. DIABETES THERAPY, 2021, 12 (01) : 211 - 222
  • [4] Efficacy and Safety of Once Weekly Dulaglutide in East Asian Patients with Type 2 Diabetes: Subgroup Analysis by Potential Influential Factors
    Jianhua Ma
    Bin Zhang
    Jianing Hou
    Yongde Peng
    [J]. Diabetes Therapy, 2021, 12 : 211 - 222
  • [5] Efficacy and Safety of Once-Weekly Dulaglutide in Type 2 Diabetes Patients Using Insulin: Exploratory Subgroup Analysis by Insulin Regimen
    Yukiko Onishi
    Hitoshi Ishii
    Tomonori Oura
    Masakazu Takeuchi
    [J]. Diabetes Therapy, 2020, 11 : 735 - 745
  • [6] Efficacy and Safety of Once-Weekly Dulaglutide in Type 2 Diabetes Patients Using Insulin: Exploratory Subgroup Analysis by Insulin Regimen
    Onishi, Yukiko
    Ishii, Hitoshi
    Oura, Tomonori
    Takeuchi, Masakazu
    [J]. DIABETES THERAPY, 2020, 11 (03) : 735 - 745
  • [7] The efficacy and safety of once-weekly, subcutaneous dulaglutide monotherapy compared to glimepiride in Asian patients with type 2 diabetes mellitus
    Wang, W.
    Huang, C. -N.
    Young, M. -C.
    Li, P.
    Gu, L.
    Yang, J.
    [J]. DIABETOLOGIA, 2015, 58 : S375 - S375
  • [8] Once-Weekly Dulaglutide for the Treatment of Youths with Type 2 Diabetes
    Arslanian, Silva A.
    Hannon, Tamara
    Zeitler, Philip
    Chao, Lily C.
    Boucher-Berry, Claudia
    Barrientos-Perez, Margarita
    Bismuth, Elise
    Dib, Sergio
    Cho, Jang Ik
    Cox, David
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2022, 387 (05): : 433 - 443
  • [9] Once-Weekly Dulaglutide for Treatment of Youths with Type 2 Diabetes
    Werth, Victoria P.
    Barbey, Catherine
    Franchimont, Nathalie
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2022, 387 (16): : 1529 - 1529
  • [10] Pharmacokinetics of Once Weekly Dulaglutide in Patients with Type 2 Diabetes Mellitus
    De la Pena, Amparo
    Loghin, Corina
    Cui, Xuewei
    Zhang, Xin
    Geiser, Jeanne S.
    Martin, Jennifer A.
    Chien, Jenny Y.
    [J]. DIABETES, 2014, 63 : A251 - A252
12345